News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,498 Results
Type
Article (74725)
Company Profile (390)
Press Release (749353)
Multimedia
Podcasts (164)
Webinars (29)
Section
Business (221634)
Career Advice (2996)
Deals (38013)
Drug Delivery (159)
Drug Development (88412)
Employer Resources (189)
FDA (17837)
Job Trends (16549)
News (377396)
Policy (37223)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3027)
Academic (2)
Accelerated approval (46)
Adcomms (38)
Allergies (182)
Alliances (54857)
ALS (219)
Alzheimer's disease (1911)
Antibody-drug conjugate (ADC) (478)
Approvals (18127)
Artificial intelligence (734)
Autoimmune disease (289)
Automation (56)
Bankruptcy (393)
Best Places to Work (12505)
BIOSECURE Act (21)
Biosimilars (236)
Biotechnology (241)
Bladder cancer (192)
Brain cancer (78)
Breast cancer (782)
Cancer (6047)
Cardiovascular disease (508)
Career advice (2552)
Career pathing (47)
CAR-T (346)
CDC (72)
Celiac Disease (3)
Cell therapy (940)
Cervical cancer (48)
Clinical research (75755)
Collaboration (2214)
Company closure (7)
Compensation (1391)
Complete response letters (95)
COVID-19 (3010)
CRISPR (117)
C-suite (1174)
Cystic fibrosis (157)
Data (7856)
Decentralized trials (3)
Denatured (49)
Depression (183)
Dermatology (83)
Diabetes (614)
Diagnostics (7433)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (341)
Drug pricing (239)
Drug shortages (34)
Duchenne muscular dystrophy (302)
Earnings (95342)
Editorial (77)
Employer branding (24)
Employer resources (166)
Events (132580)
Executive appointments (1151)
FDA (21610)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1815)
Gene editing (253)
Generative AI (69)
Gene therapy (779)
GLP-1 (1203)
Government (5482)
Grass and pollen (8)
Guidances (409)
Healthcare (20873)
HIV (86)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (100)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (181)
Infectious disease (3378)
Inflammatory bowel disease (236)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (295)
Interviews (577)
IPO (17364)
IRA (60)
Job creations (4387)
Job search strategy (2077)
JPM (70)
Kidney cancer (22)
Labor market (100)
Layoffs (645)
Leadership (47)
Legal (9134)
Liver cancer (107)
Longevity (34)
Lung cancer (797)
Lymphoma (432)
Machine learning (61)
Management (65)
Manufacturing (1076)
MASH (202)
Medical device (14908)
Medtech (15023)
Mergers & acquisitions (21888)
Metabolic disorders (1626)
mRNA (236)
Multiple sclerosis (195)
NASH (24)
Neurodegenerative disease (453)
Neuropsychiatric disorders (121)
Neuroscience (3520)
Neurotech (1)
NextGen: Class of 2026 (7400)
Non-profit (5101)
Now hiring (77)
Obesity (782)
Opinion (351)
Ovarian cancer (221)
Pain (267)
Pancreatic cancer (306)
Parkinson's disease (381)
Partnered (35)
Patents (611)
Patient recruitment (690)
Peanut (66)
People (65595)
Pharmaceutical (78)
Pharmacy benefit managers (35)
Phase 1 (23512)
Phase 2 (33064)
Phase 3 (24722)
Pipeline (8423)
Policy (367)
Postmarket research (3267)
Preclinical (10477)
Press Release (72)
Prostate cancer (308)
Psychedelics (68)
Radiopharmaceuticals (346)
Rare diseases (1160)
Real estate (6857)
Recruiting (77)
Regulatory (28263)
Reports (58)
Research institute (2738)
Resumes & cover letters (464)
Rett syndrome (37)
RNA editing (23)
RSV (97)
Schizophrenia (189)
Series A (309)
Series B (223)
Service/supplier (19)
Sickle cell disease (120)
Special edition (29)
Spinal muscular atrophy (184)
Sponsored (52)
Startups (4087)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (99)
The Weekly (112)
Vaccines (1240)
Venture capital (117)
Weight loss (528)
Women's health (128)
Worklife (24)
Date
Today (209)
Last 7 days (913)
Last 30 days (3362)
Last 365 days (32158)
2026 (12056)
2025 (32119)
2024 (37254)
2023 (42248)
2022 (53555)
2021 (58297)
2020 (57301)
2019 (50828)
2018 (38590)
2017 (35491)
2016 (35992)
2015 (42373)
2014 (36649)
2013 (32912)
2012 (34659)
2011 (34907)
2010 (33987)
Location
Africa (1083)
Alabama (97)
Alaska (7)
Arizona (377)
Arkansas (16)
Asia (47085)
Australia (8642)
California (13391)
Canada (3772)
China (1403)
Colorado (578)
Connecticut (594)
Delaware (408)
Europe (107653)
Florida (1988)
Georgia (442)
Hawaii (4)
Idaho (68)
Illinois (1131)
India (93)
Indiana (622)
Iowa (24)
Japan (537)
Kansas (136)
Kentucky (54)
Louisiana (44)
Maine (87)
Maryland (1637)
Massachusetts (9723)
Michigan (396)
Minnesota (748)
Mississippi (7)
Missouri (159)
Montana (37)
Nebraska (29)
Nevada (146)
New Hampshire (92)
New Jersey (3566)
New Mexico (32)
New York (3535)
North Carolina (1795)
North Dakota (10)
Northern California (6649)
Ohio (414)
Oklahoma (25)
Oregon (46)
Pennsylvania (2678)
Puerto Rico (30)
Rhode Island (52)
South America (1442)
South Carolina (87)
South Dakota (2)
Southern California (5279)
Tennessee (214)
Texas (2144)
United States (47910)
Utah (404)
Vermont (1)
Virginia (334)
Washington D.C. (88)
Washington State (1098)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
824,498 Results for "syneos health formerly known as inc research inventiv health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization
May 7, 2026
·
2 min read
Press Releases
KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization
April 30, 2026
·
2 min read
Sponsored
Turn health data into impact: Browns University’s online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
April 27, 2026
·
3 min read
Press Releases
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
January 9, 2026
·
2 min read
Press Releases
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
May 6, 2026
·
5 min read
Press Releases
FOMAT Becomes Largest Embedded Research Organization in the U.S. with Acquisition of Topography Health’s Research Sites
May 3, 2026
·
3 min read
Press Releases
Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research
April 30, 2026
·
4 min read
Press Releases
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
March 18, 2026
·
4 min read
Press Releases
Conv2X 2026 Decentralized Health Summit in Cambridge, MA Brings Together BioPharma, Clinical Research, and Health Innovation Leaders
May 4, 2026
·
1 min read
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
1 of 82,450
Next
